成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook >> journal list >> Anais brasileiros de dermatologia >>article
Anais brasileiros de dermatologia

Anais brasileiros de dermatologia

IF: 2.6
Download PDF

Ingenol mebutate in the treatment of actinic keratoses: clearance rate and adverse effects*

Published:1 July 2018 DOI: 10.1590/abd1806-4841.20186982 PMID: 30066759
Maria Isabel Ramos Saraiva , Larissa Karine Leite Portocarrero , Marcella Amaral Horta Barbosa Vieira , Bethania Cabral Cavalli Swiczar , Andrezza Telles Westin

Abstract

Background:

Actinic keratoses are benign intraepithelial skin neoplasms that develop in photoexposed areas and can progress to invasive carcinoma. They are seen frequently in dermatological practice, occurring in 5.1% of consultations. Ingenol mebutate (IM) was recently approved in Brazil as a topical therapy for field cancerization in actinic keratosis.

Objective:

To evaluate the clearance rate and adverse events in the treatment of actinic keratoses with ingenol mebutate.

Methods:

A longitudinal, prospective, non-randomized, interventional, open, single-center study was conducted. Patients with actinic keratoses applied ingenol mebutate on a 25cm2 area of the face and/or scalp for three consecutive days (0.015%) or on the forearm for two days (0.05%).

Results:

27 patients completed the protocol, of whom 13 on the face and/or scalp and 14 on the forearm. Complete clearance occurred in 53.8% in the first group and 42.8% in the second. Partial response was observed in 15.4% and 35.7%, respectively. The most common side effects were erythema, edema, desquamation, pruritus, and local erosion.

Study limitations:

The study had a small sample and was not randomized, double-blind, placebo-controlled, or vehicle-controlled.

Conclusion:

Ingenol mebutate is well-tolerated for the treatment of actinic keratosis, with good patient adherence thanks to the short treatment period.

Substances (1)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Ingenol mebutate 75567-37-2 C25H34O6 161 suppliers $74.00-$2150.00

Similar articles

IF:2.8

Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice.

Therapeutics and Clinical Risk Management Nevena Skroza, Nicoletta Bernardini,etc Published: 4 October 2018
IF:3.2

Chlorhexidine in Dentistry: Pharmacology, Uses, and Adverse Effects

International dental journal Frank Poppolo Deus , Aviv Ouanounou,etc Published: 1 June 2022
IF:0

Corticosteroid-related adverse effects

Reactions Weekly Published: 1 January 1991